Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Amgen’s Xgeva Approved in Europe

By Pharmaceutical Processing | July 18, 2011

European regulators approved Amgen’s Xgeva (denosumab) for the prevention of
skeletal-related events (SREs) in adults with bone metastases from solid
tumours, the company reported Friday. In making its decision, which followed a
positive recommendation in May, the European Commission also
granted the compound an additional year of market exclusivity.

The company noted that the approval was based on data from three late-stage
studies, in which Xgeva demonstrated a “clinically meaningful improvement” in
preventing SREs compared to Novartis’ Zometa (zoledronic acid). According to
Amgen, in patients with breast or prostate cancer, Xgeva was shown to be
superior to Zometa in reducing the risk of SREs, while in those with bone
metastases due to other solid tumours or multiple myeloma, the RANK ligand
inhibitor was non-inferior to Novartis’ drug.

Xgeva is also approved in this indication in the US and Canada, while in Japan, Amgen’s partner Daiichi Sankyo
submitted a marketing application last year.

 

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE